APO Research
Talk to an analyst

APO RESEARCH · REPORT

Melanocyte Protein PMEL

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Melanocyte Protein PMEL Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025180 pages

Choose your research edition.

Industry ResearchMelanocyte Protein PMEL Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Melanocyte Protein PMEL Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Melanocyte Protein PMEL Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Melanocyte Protein PMEL Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Melanocyte Protein PMEL Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Melanocyte Protein PMEL market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Melanocyte Protein PMEL is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Melanocyte Protein PMEL is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Melanocyte Protein PMEL is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Melanocyte Protein PMEL is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Melanocyte Protein PMEL include Vault Pharma Inc., Scancell Holdings Plc, Immunomic Therapeutics, Inc., ImmunoCellular Therapeutics, Ltd. and Antigen Express, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Melanocyte Protein PMEL market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Melanocyte Protein PMEL and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Melanocyte Protein PMEL sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Melanocyte Protein PMEL market size, projected growth trends, production technologies, key applications, and end-use industries.

Melanocyte Protein PMEL Segment by Company

Vault Pharma Inc.

Scancell Holdings Plc

Immunomic Therapeutics, Inc.

ImmunoCellular Therapeutics, Ltd.

Antigen Express, Inc.

Melanocyte Protein PMEL Segment by Type

VPI-121

SCIB-1

AE-M vaccine

Others

Melanocyte Protein PMEL Segment by Application

Metastatic Melanoma

Melanoma

Glioblastoma Multiforme

Melanocyte Protein PMEL Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melanocyte Protein PMEL market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Melanocyte Protein PMEL and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melanocyte Protein PMEL.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Melanocyte Protein PMEL market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Melanocyte Protein PMEL manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Melanocyte Protein PMEL in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Melanocyte Protein PMEL in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Melanocyte Protein PMEL Industry Trends Table 2. Melanocyte Protein PMEL Industry Drivers Table 3. Melanocyte Protein PMEL Industry Opportunities and Challenges Table 4. Melanocyte Protein PMEL Industry Restraints Table 5. Global Melanocyte Protein PMEL Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Melanocyte Protein PMEL Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Melanocyte Protein PMEL Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Melanocyte Protein PMEL Sales Market Share by Manufacturers Table 9. Global Melanocyte Protein PMEL Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Melanocyte Protein PMEL Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Melanocyte Protein PMEL Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Melanocyte Protein PMEL Manufacturers, Product Type & Application Table 13. Global Melanocyte Protein PMEL Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Melanocyte Protein PMEL by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of VPI-121 Table 17. Major Manufacturers of SCIB-1 Table 18. Major Manufacturers of AE-M vaccine Table 19. Major Manufacturers of Others Table 20. Global Melanocyte Protein PMEL Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Melanocyte Protein PMEL Sales by Type (2021-2026) & (K Units) Table 22. Global Melanocyte Protein PMEL Sales by Type (2027-2032) & (K Units) Table 23. Global Melanocyte Protein PMEL Sales Market Share by Type (2021-2026) Table 24. Global Melanocyte Protein PMEL Sales Market Share by Type (2027-2032) Table 25. Global Melanocyte Protein PMEL Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Melanocyte Protein PMEL Revenue by Type (2021-2026) & (K Units) Table 27. Global Melanocyte Protein PMEL Revenue by Type (2027-2032) & (K Units) Table 28. Global Melanocyte Protein PMEL Revenue Market Share by Type (2021-2026) Table 29. Global Melanocyte Protein PMEL Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Metastatic Melanoma Table 31. Major Manufacturers of Melanoma Table 32. Major Manufacturers of Glioblastoma Multiforme Table 33. Global Melanocyte Protein PMEL Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Melanocyte Protein PMEL Sales by Application (2021-2026) & (K Units) Table 35. Global Melanocyte Protein PMEL Sales by Application (2027-2032) & (K Units) Table 36. Global Melanocyte Protein PMEL Sales Market Share by Application (2021-2026) Table 37. Global Melanocyte Protein PMEL Sales Market Share by Application (2027-2032) Table 38. Global Melanocyte Protein PMEL Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Melanocyte Protein PMEL Revenue by Application (2021-2026) & (K Units) Table 40. Global Melanocyte Protein PMEL Revenue by Application (2027-2032) & (K Units) Table 41. Global Melanocyte Protein PMEL Revenue Market Share by Application (2021-2026) Table 42. Global Melanocyte Protein PMEL Revenue Market Share by Application (2027-2032) Table 43. Global Melanocyte Protein PMEL Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Melanocyte Protein PMEL Sales by Region (2021-2026) & (K Units) Table 45. Global Melanocyte Protein PMEL Sales Market Share by Region (2021-2026) Table 46. Global Melanocyte Protein PMEL Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Melanocyte Protein PMEL Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Melanocyte Protein PMEL Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Melanocyte Protein PMEL Sales by Country (2021-2026) & (K Units) Table 50. North America Melanocyte Protein PMEL Sales by Country (2027-2032) & (K Units) Table 51. Europe Melanocyte Protein PMEL Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Melanocyte Protein PMEL Sales by Country (2021-2026) & (K Units) Table 53. Europe Melanocyte Protein PMEL Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Melanocyte Protein PMEL Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Melanocyte Protein PMEL Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Melanocyte Protein PMEL Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Melanocyte Protein PMEL Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Melanocyte Protein PMEL Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Melanocyte Protein PMEL Sales by Country (2027-2032) & (K Units) Table 60. Global Melanocyte Protein PMEL Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Melanocyte Protein PMEL Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Melanocyte Protein PMEL Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Melanocyte Protein PMEL Revenue Market Share by Region (2021-2026) Table 64. Global Melanocyte Protein PMEL Revenue Market Share by Region (2027-2032) Table 65. Vault Pharma Inc. Company Information Table 66. Vault Pharma Inc. Business Overview Table 67. Vault Pharma Inc. Melanocyte Protein PMEL Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Vault Pharma Inc. Melanocyte Protein PMEL Product Portfolio Table 69. Vault Pharma Inc. Recent Development Table 70. Scancell Holdings Plc Company Information Table 71. Scancell Holdings Plc Business Overview Table 72. Scancell Holdings Plc Melanocyte Protein PMEL Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Scancell Holdings Plc Melanocyte Protein PMEL Product Portfolio Table 74. Scancell Holdings Plc Recent Development Table 75. Immunomic Therapeutics, Inc. Company Information Table 76. Immunomic Therapeutics, Inc. Business Overview Table 77. Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Product Portfolio Table 79. Immunomic Therapeutics, Inc. Recent Development Table 80. ImmunoCellular Therapeutics, Ltd. Company Information Table 81. ImmunoCellular Therapeutics, Ltd. Business Overview Table 82. ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Product Portfolio Table 84. ImmunoCellular Therapeutics, Ltd. Recent Development Table 85. Antigen Express, Inc. Company Information Table 86. Antigen Express, Inc. Business Overview Table 87. Antigen Express, Inc. Melanocyte Protein PMEL Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Antigen Express, Inc. Melanocyte Protein PMEL Product Portfolio Table 89. Antigen Express, Inc. Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Melanocyte Protein PMEL Distributors List Table 93. Melanocyte Protein PMEL Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Melanocyte Protein PMEL Product Image Figure 2. Global Melanocyte Protein PMEL Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Melanocyte Protein PMEL Market Size (2021-2032) & (US$ Million) Figure 4. Global Melanocyte Protein PMEL Sales (2021-2032) & (K Units) Figure 5. Global Melanocyte Protein PMEL Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Melanocyte Protein PMEL Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. VPI-121 Image Figure 9. SCIB-1 Image Figure 10. AE-M vaccine Image Figure 11. Others Image Figure 12. Global Melanocyte Protein PMEL Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Melanocyte Protein PMEL Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Melanocyte Protein PMEL Sales Market Share by Type (2021-2032) Figure 15. Global Melanocyte Protein PMEL Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Melanocyte Protein PMEL Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Melanocyte Protein PMEL Revenue Market Share by Type (2021-2032) Figure 18. Metastatic Melanoma Image Figure 19. Melanoma Image Figure 20. Glioblastoma Multiforme Image Figure 21. Global Melanocyte Protein PMEL Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Melanocyte Protein PMEL Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Melanocyte Protein PMEL Sales Market Share by Application (2021-2032) Figure 24. Global Melanocyte Protein PMEL Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Melanocyte Protein PMEL Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Melanocyte Protein PMEL Revenue Market Share by Application (2021-2032) Figure 27. North America Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Melanocyte Protein PMEL Sales Market Share by Country (2021-2032) Figure 29. U.S. Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Melanocyte Protein PMEL Sales Market Share by Country (2021-2032) Figure 34. Germany Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Melanocyte Protein PMEL Sales Market Share by Country (2021-2032) Figure 41. China Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Melanocyte Protein PMEL Sales Market Share by Country (2021-2032) Figure 49. Brazil Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Melanocyte Protein PMEL Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Melanocyte Protein PMEL Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Melanocyte Protein PMEL Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Melanocyte Protein PMEL Revenue (2021-2032) & (US$ Million) Figure 60. North America Melanocyte Protein PMEL Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Melanocyte Protein PMEL Revenue (2021-2032) & (US$ Million) Figure 62. Europe Melanocyte Protein PMEL Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Melanocyte Protein PMEL Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Melanocyte Protein PMEL Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Melanocyte Protein PMEL Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Melanocyte Protein PMEL Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Melanocyte Protein PMEL Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Melanocyte Protein PMEL Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • VPI-121
  • SCIB-1
  • AE-M vaccine
  • Others
Applications
  • Metastatic Melanoma
  • Melanoma
  • Glioblastoma Multiforme
Companies covered
  • Vault Pharma Inc.
  • Scancell Holdings Plc
  • Immunomic Therapeutics, Inc.
  • ImmunoCellular Therapeutics, Ltd.
  • Antigen Express, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Melanocyte Protein PMEL Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Melanocyte Protein PMEL Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Melanocyte Protein PMEL Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Melanocyte Protein PMEL Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Melanocyte Protein PMEL Market Dynamics
  1. 2.1 Melanocyte Protein PMEL Industry Trends
  2. 2.2 Melanocyte Protein PMEL Industry Drivers
  3. 2.3 Melanocyte Protein PMEL Industry Opportunities and Challenges
  4. 2.4 Melanocyte Protein PMEL Industry Restraints
3 Melanocyte Protein PMEL Market by Manufacturers
  1. 3.1 Global Melanocyte Protein PMEL Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Melanocyte Protein PMEL Sales by Manufacturers (2021-2026)
  3. 3.3 Global Melanocyte Protein PMEL Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Melanocyte Protein PMEL Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Melanocyte Protein PMEL Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Melanocyte Protein PMEL Manufacturers, Product Type & Application
  7. 3.7 Global Melanocyte Protein PMEL Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Melanocyte Protein PMEL Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Melanocyte Protein PMEL Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Melanocyte Protein PMEL Tier 1, Tier 2, and Tier 3
4 Melanocyte Protein PMEL Market by Type
  1. 4.1 Melanocyte Protein PMEL Type Introduction
  2. 4.1.1 VPI-121
  3. 4.1.2 SCIB-1
  4. 4.1.3 AE-M vaccine
  5. 4.1.4 Others
  6. 4.2 Global Melanocyte Protein PMEL Sales by Type
  7. 4.2.1 Global Melanocyte Protein PMEL Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Melanocyte Protein PMEL Sales by Type (2021-2032)
  9. 4.2.3 Global Melanocyte Protein PMEL Sales Market Share by Type (2021-2032)
  10. 4.3 Global Melanocyte Protein PMEL Revenue by Type
  11. 4.3.1 Global Melanocyte Protein PMEL Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Melanocyte Protein PMEL Revenue by Type (2021-2032)
  13. 4.3.3 Global Melanocyte Protein PMEL Revenue Market Share by Type (2021-2032)
5 Melanocyte Protein PMEL Market by Application
  1. 5.1 Melanocyte Protein PMEL Application Introduction
  2. 5.1.1 Metastatic Melanoma
  3. 5.1.2 Melanoma
  4. 5.1.3 Glioblastoma Multiforme
  5. 5.2 Global Melanocyte Protein PMEL Sales by Application
  6. 5.2.1 Global Melanocyte Protein PMEL Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Melanocyte Protein PMEL Sales by Application (2021-2032)
  8. 5.2.3 Global Melanocyte Protein PMEL Sales Market Share by Application (2021-2032)
  9. 5.3 Global Melanocyte Protein PMEL Revenue by Application
  10. 5.3.1 Global Melanocyte Protein PMEL Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Melanocyte Protein PMEL Revenue by Application (2021-2032)
  12. 5.3.3 Global Melanocyte Protein PMEL Revenue Market Share by Application (2021-2032)
6 Global Melanocyte Protein PMEL Sales by Region
  1. 6.1 Global Melanocyte Protein PMEL Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Melanocyte Protein PMEL Sales by Region (2021-2032)
  3. 6.2.1 Global Melanocyte Protein PMEL Sales by Region (2021-2026)
  4. 6.2.2 Global Melanocyte Protein PMEL Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Melanocyte Protein PMEL Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Melanocyte Protein PMEL Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Melanocyte Protein PMEL Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Melanocyte Protein PMEL Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Melanocyte Protein PMEL Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Melanocyte Protein PMEL Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Melanocyte Protein PMEL Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Melanocyte Protein PMEL Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Melanocyte Protein PMEL Revenue by Region
  1. 7.1 Global Melanocyte Protein PMEL Revenue by Region
  2. 7.1.1 Global Melanocyte Protein PMEL Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Melanocyte Protein PMEL Revenue by Region (2021-2026)
  4. 7.1.3 Global Melanocyte Protein PMEL Revenue by Region (2027-2032)
  5. 7.1.4 Global Melanocyte Protein PMEL Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Melanocyte Protein PMEL Revenue (2021-2032)
  8. 7.2.2 North America Melanocyte Protein PMEL Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Melanocyte Protein PMEL Revenue (2021-2032)
  11. 7.3.2 Europe Melanocyte Protein PMEL Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Melanocyte Protein PMEL Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Melanocyte Protein PMEL Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Melanocyte Protein PMEL Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Melanocyte Protein PMEL Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Vault Pharma Inc.
  2. 8.1.1 Vault Pharma Inc. Company Information
  3. 8.1.2 Vault Pharma Inc. Business Overview
  4. 8.1.3 Vault Pharma Inc. Melanocyte Protein PMEL Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Vault Pharma Inc. Melanocyte Protein PMEL Product Portfolio
  6. 8.1.5 Vault Pharma Inc. Recent Developments
  7. 8.2 Scancell Holdings Plc
  8. 8.2.1 Scancell Holdings Plc Company Information
  9. 8.2.2 Scancell Holdings Plc Business Overview
  10. 8.2.3 Scancell Holdings Plc Melanocyte Protein PMEL Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Scancell Holdings Plc Melanocyte Protein PMEL Product Portfolio
  12. 8.2.5 Scancell Holdings Plc Recent Developments
  13. 8.3 Immunomic Therapeutics, Inc.
  14. 8.3.1 Immunomic Therapeutics, Inc. Company Information
  15. 8.3.2 Immunomic Therapeutics, Inc. Business Overview
  16. 8.3.3 Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Immunomic Therapeutics, Inc. Melanocyte Protein PMEL Product Portfolio
  18. 8.3.5 Immunomic Therapeutics, Inc. Recent Developments
  19. 8.4 ImmunoCellular Therapeutics, Ltd.
  20. 8.4.1 ImmunoCellular Therapeutics, Ltd. Company Information
  21. 8.4.2 ImmunoCellular Therapeutics, Ltd. Business Overview
  22. 8.4.3 ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ImmunoCellular Therapeutics, Ltd. Melanocyte Protein PMEL Product Portfolio
  24. 8.4.5 ImmunoCellular Therapeutics, Ltd. Recent Developments
  25. 8.5 Antigen Express, Inc.
  26. 8.5.1 Antigen Express, Inc. Company Information
  27. 8.5.2 Antigen Express, Inc. Business Overview
  28. 8.5.3 Antigen Express, Inc. Melanocyte Protein PMEL Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Antigen Express, Inc. Melanocyte Protein PMEL Product Portfolio
  30. 8.5.5 Antigen Express, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Melanocyte Protein PMEL Value Chain Analysis
  2. 9.1.1 Melanocyte Protein PMEL Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Melanocyte Protein PMEL Production Mode & Process
  6. 9.2 Melanocyte Protein PMEL Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Melanocyte Protein PMEL Distributors
  9. 9.2.3 Melanocyte Protein PMEL Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst